Les Echos.fr - February 22, 2011
The tender offer (bid) of DSM, the Dutch pharmaceutical company, Martek the U.S., specializing in nutritional products, has been completed successfully. The bid, launched in December 2010, has a value of 1.09 billion dollars.
0 comments:
Post a Comment